Chinese english Germany Japanese Korea

2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide

2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide Struktur
2061549-77-5
CAS-Nr.
2061549-77-5
Englisch Name:
2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide
Synonyma:
2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide;1H-1,4-Benzodiazepine-3-acetamide, 2,3,4,5-tetrahydro-N-[[3-[4-(1-methylethoxy)phenyl]-1,2,4-oxadiazol-5-yl]methyl]-2,5-dioxo-
CBNumber:
CB44306946
Summenformel:
C23H23N5O5
Molgewicht:
449.46
MOL-Datei:
2061549-77-5.mol
Request For Quotation

2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide Eigenschaften

Dichte
1.277±0.06 g/cm3(Predicted)
pka
12.25±0.40(Predicted)

Sicherheit

2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide Chemische Eigenschaften,Einsatz,Produktion Methoden

2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6349 50
  • 2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]acetamide
  • 1H-1,4-Benzodiazepine-3-acetamide, 2,3,4,5-tetrahydro-N-[[3-[4-(1-methylethoxy)phenyl]-1,2,4-oxadiazol-5-yl]methyl]-2,5-dioxo-
  • 2061549-77-5
Copyright 2019 © ChemicalBook. All rights reserved